How do Adderall (mixed amphetamine salts) extended‑release (XR) and immediate‑release (IR) formulations affect omeprazole, and how does omeprazole affect Adderall XR and IR?

Drug Interaction Between Adderall (XR/IR) and Omeprazole

Omeprazole significantly alters the absorption kinetics of Adderall XR but does not affect total drug exposure for either Adderall XR or IR, and Adderall does not affect omeprazole's efficacy or safety. The primary clinical concern is unpredictable timing of symptom control with Adderall XR when combined with omeprazole, not reduced effectiveness.

Effect of Omeprazole on Adderall

Adderall XR (Extended-Release)

The interaction is clinically significant for timing but not for total exposure. A pharmacokinetic study directly examined this interaction 1:

• Total amphetamine exposure remains unchanged: Cmax and AUC are not significantly affected by omeprazole co-administration
• Absorption timing becomes unpredictable: Approximately 50-60% of patients experience earlier Tmax (≥1 hour earlier) when taking Adderall XR with omeprazole 1
• Mechanism: Omeprazole raises gastric pH by suppressing acid production. Adderall XR uses a dual-bead delivery system where the second bead's release depends on pH-sensitive coating. Reduced stomach acid compromises this pulsed delivery mechanism, causing premature release of the delayed-release component 1

Clinical implications: Patients may experience:

• Earlier onset of stimulant effects than expected
• Shorter duration of afternoon coverage
• More pronounced "wearing off" effects in late afternoon/evening
• Inconsistent symptom control day-to-day

Adderall IR (Immediate-Release)

The interaction is not clinically significant 1:

• Total amphetamine exposure unchanged
• Tmax minimally affected (only 25% of subjects showed ≥1 hour earlier Tmax)
• No clear trend toward unpredictable absorption
• Reason: IR formulation does not rely on pH-dependent coating for release

Effect of Adderall on Omeprazole

There is no documented interaction where amphetamines affect omeprazole's pharmacokinetics, efficacy, or safety. The provided evidence includes:

• Omeprazole's metabolism occurs primarily through CYP2C19 and CYP3A4 2
• Amphetamines are not inhibitors or inducers of these enzyme systems 3
• Amphetamines undergo different metabolic pathways (p-hydroxylation, N-demethylation, deamination) with up to 80% excreted unchanged in urine 3

Practical Management Recommendations

If Patient is on Adderall XR + Omeprazole:

1. Monitor for altered symptom control patterns: Ask specifically about timing of ADHD symptom relief and duration of effect
2. Consider switching to Adderall IR if unpredictable coverage becomes problematic—IR formulation is not meaningfully affected by omeprazole 1
3. Alternative: Switch to lisdexamfetamine (Vyvanse), which showed no clear trend toward unpredictable absorption with omeprazole 1
4. Do not separate dosing times: The interaction is pH-mediated and persists throughout the day while omeprazole is active; separating doses by hours will not prevent the interaction 1

If Patient is on Adderall IR + Omeprazole:

No dosing adjustments needed. Continue both medications as prescribed 1.

Regarding Omeprazole Dosing:

• Omeprazole should be taken before the first meal of the day for optimal acid suppression 2, 4
• Adderall can be taken with or without food, though absorption may increase slightly after meals 3
• The timing of omeprazole relative to Adderall does not prevent the pH-mediated interaction with XR formulations 1

Key Caveats

• The interaction data comes from a single well-designed crossover study in healthy adults 1; real-world variability may differ
• Individual patients may not experience altered absorption timing, but approximately half will with XR formulations
• The interaction does not reduce total drug exposure or efficacy—it only affects timing and predictability of effect
• No safety concerns or adverse events result from this combination beyond those expected from each drug individually 1